[QNT Q2 2026 Earnings Call] Quantinuum Ups Guidance to $32M, Bookings Surge Past $81M in Post-IPO Debut — BigGo Finance
Quantinuum (QNT) reported Q2 FY2026 revenue of $8M, up 279% year over year, and raised its 2026 revenue outlook to $28M to $32M. The company cited bookings of about $81M year to date, driven by a multi-year Oracle deal to deploy its Helios system in U.S. OCI data centers. It also discussed Sol validation and quantum error-correction milestones.
How this was made
The 30-second read
Why it matters
The raised 2026 revenue outlook and bookings acceleration are the core trading catalysts, while the Oracle OCI deployment details shift attention to delivery timing and revenue recognition mechanics. Hardware validation and error-correction progress add credibility to the roadmap but are less directly tied to near-term financials.
Market read
Traders get a fresh earnings-and-guidance package plus a concrete enterprise deployment story (Oracle OCI) that can re-rate expectations for commercialization timelines.
What to watch
Adjusted EBITDA loss widened to $68M and GAAP net loss includes $447.5M IPO stock-based comp, so investors may scrutinize cash burn and margin path beyond headline revenue growth.
Background
Quantinuum used its first quarterly report as a public company to frame accelerating demand for trapped-ion quantum systems, alongside hardware roadmap milestones and an Oracle partnership.
Ticker impact
Quantinuum raised 2026 revenue guidance to $28–32M and said YTD bookings are about $81M after a post-IPO Oracle deal.
Likely positive bias for the stock on open, with volatility driven by expectations for 2027 delivery timing and margin trajectory.
The article provides specific, time-sensitive disclosures: raised revenue outlook, bookings acceleration, and a multi-year Oracle OCI deployment with delivery-weighted revenue in early 2027. Offsetting factors include widened adjusted EBITDA loss and GAAP net loss inflated by IPO-related stock-based comp.
Market effects
Supports a bullish read-through for quantum hardware commercialization and enterprise cloud/on-prem integration demand.
US data-center deployment narrative may attract incremental US-focused quantum funding and partner interest.
Oracle OCI placement and Singapore system shipment reinforce cross-region scaling of trapped-ion deployments.
Counterpoint
Bookings and guidance may be timing-dependent, with most revenue deferred to system delivery in early 2027, limiting near-term earnings power.
Key entities
- companyQuantinuum
Trapped-ion quantum computing provider reporting Q2 results, raised 2026 revenue guidance, and disclosed Oracle OCI deployment and bookings pipeline.
- companyOracle
Purchasing partner deploying a Helios quantum computer inside Oracle Cloud Infrastructure data centers in the US under a multi-year deal.
- companyHoneywell Aerospace
Manufactured the first Sol trap chip referenced as returning from the foundry for validation.
- companyGlobalFoundries
Named as a partner in Quantinuum’s LOI for CHIPS R&D milestone-based funding.
